Klaus K. Wilgenbus
Chief Executive Officer at Allecra Therapeutics GmbH
Profile
Klaus K.
Wilgenbus is the Chief Executive Officer & Managing Director at Allecra Therapeutics GmbH since 2018.
He was the Chief Executive Officer & Director at Karolinska Development AB from 2012 to 2014, and the Chief Executive Officer at Northern Data AG from 2016 to 2017.
Dr. Wilgenbus also held positions as Director at Actimis Pharmaceuticals, Inc. and Corporate SVP-Business Development & Licensing at Boehringer Ingelheim GmbH.
He earned a doctorate degree from RWTH Aachen University in 1989.
Klaus K. Wilgenbus active positions
| Companies | Position | Start |
|---|---|---|
Allecra Therapeutics GmbH
 Allecra Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Allecra Therapeutics GmbH focuses on the development of novel treatments to combat multi drug-resistant bacterial infections. The firm serves the bio and pharmaceutical industry. The company was founded by Nicholas Benedict and Stuart Shapiro in 2013 and is headquartered in Weil am Rhein, Germany. | Chief Executive Officer | 2018-08-22 |
Former positions of Klaus K. Wilgenbus
| Companies | Position | End |
|---|---|---|
| NORTHERN DATA AG | Chief Executive Officer | 2017-11-22 |
| KAROLINSKA DEVELOPMENT AB | Chief Executive Officer | 2014-10-14 |
Actimis Pharmaceuticals, Inc.
 Actimis Pharmaceuticals, Inc. BiotechnologyHealth Technology Actimis Pharmaceuticals, Inc. provides pharmaceutical research and development services. it focuses on the development of small therapeutics for respiratory and inflammatory disorders. The company was founded by Kevin B. Bacon in November 2004 and is headquartered in San Diego, CA. | Director/Board Member | - |
Boehringer Ingelheim GmbH
 Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | Corporate Officer/Principal | - |
Training of Klaus K. Wilgenbus
| RWTH Aachen University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| KAROLINSKA DEVELOPMENT AB | Finance |
| NORTHERN DATA AG | Technology Services |
| Private companies | 3 |
|---|---|
Boehringer Ingelheim GmbH
Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | Health Technology |
Actimis Pharmaceuticals, Inc.
Actimis Pharmaceuticals, Inc. BiotechnologyHealth Technology Actimis Pharmaceuticals, Inc. provides pharmaceutical research and development services. it focuses on the development of small therapeutics for respiratory and inflammatory disorders. The company was founded by Kevin B. Bacon in November 2004 and is headquartered in San Diego, CA. | Health Technology |
Allecra Therapeutics GmbH
Allecra Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Allecra Therapeutics GmbH focuses on the development of novel treatments to combat multi drug-resistant bacterial infections. The firm serves the bio and pharmaceutical industry. The company was founded by Nicholas Benedict and Stuart Shapiro in 2013 and is headquartered in Weil am Rhein, Germany. | Health Technology |
- Stock Market
- Insiders
- Klaus K. Wilgenbus